Energy Technologies Multimodal Extracorporeal Shockwave Therapy (ESWT) Extracorporeal shockwave therapy (ESWT) is a noninvasive treatment that uses high-energy acoustic waves to induce biological and physiological effects
A systematic review of the effects of melanotan injections
Who Faces the Highest Risk from Common Medications
GLP1 Receptor Agonists (GLP1RAs) In 2006, the FDA approved the first GLP1RA, exenatide twice daily, to treat Type 2 diabetes
Discussion In our practice, GLP-1 RA initiation is considered as a potential adjunct therapy in overweight and obese people with type 1 diabetes
Derived from Gila monster, Heloderma suspectum, Exendin-4 has a longer half life than GLP-1 in the plasma, thus making it a more potent insulinotropic agent